Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Ho

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
Journal of Affective Disorders|May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countriesYena Lee, Leanna M W Lui, David Chen-Li, et al.
Psychiatry Research|July 2, 2024
Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.
CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.
Bipolar Disorders|May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorderRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research|June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Advances in Therapy|December 20, 2023
Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary AnalysisGia Han Le, Angela T H Kwan, Sabrina Wong, et al.
Journal of Affective Disorders|September 19, 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic reviewGia Han Le, Sabrina Wong, Andy Lu, et al.
Journal of Affective Disorders|May 29, 2025
The efficacy of lithium in the treatment of suicidal ideation, behavior and suicide: An updated systematic review and meta-analysis of randomized controlled trialsJames Xiaolong Wang, Gia Han Le, Sabrina Wong, et al.
CNS Spectrums|November 25, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gainTrisha Menon, Serene Lee, Xuan Yi Gong, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 8, 2020
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatmentAshley N Siegel, Nelson Rodrigues, Flora Nasri, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
Journal of Affective Disorders|May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countriesYena Lee, Leanna M W Lui, David Chen-Li, et al.
Psychiatry Research|July 2, 2024
Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysisGia Han Le, Angela T H Kwan, Ziji Guo, et al.
CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.
Bipolar Disorders|May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorderRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research|June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
Advances in Therapy|December 20, 2023
Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary AnalysisGia Han Le, Angela T H Kwan, Sabrina Wong, et al.
Journal of Affective Disorders|September 19, 2024
Electroencephalography (EEG) spectral signatures of selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs) and vortioxetine in major depressive disorder: A systematic reviewGia Han Le, Sabrina Wong, Andy Lu, et al.
Journal of Affective Disorders|May 29, 2025
The efficacy of lithium in the treatment of suicidal ideation, behavior and suicide: An updated systematic review and meta-analysis of randomized controlled trialsJames Xiaolong Wang, Gia Han Le, Sabrina Wong, et al.
CNS Spectrums|November 25, 2024
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gainTrisha Menon, Serene Lee, Xuan Yi Gong, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 8, 2020
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatmentAshley N Siegel, Nelson Rodrigues, Flora Nasri, et al.
Pageof 20